175 related articles for article (PubMed ID: 30550394)
21. The Behavioral Effects of the Antidepressant Tianeptine Require the Mu-Opioid Receptor.
Samuels BA; Nautiyal KM; Kruegel AC; Levinstein MR; Magalong VM; Gassaway MM; Grinnell SG; Han J; Ansonoff MA; Pintar JE; Javitch JA; Sames D; Hen R
Neuropsychopharmacology; 2017 Sep; 42(10):2052-2063. PubMed ID: 28303899
[TBL] [Abstract][Full Text] [Related]
22. Tianeptine: more cases of dependence.
Prescrire Int; 2012 May; 21(127):130. PubMed ID: 22844686
[No Abstract] [Full Text] [Related]
23. [Treatment with tianeptine of depressive disorders in drug addicts under withdrawal. Assessment of efficacy and study of dependence].
Lôo H; Hantzberg P; Defrance R; Kamoun A; Deniker P
Encephale; 1987; 13(5):295-9. PubMed ID: 3322802
[TBL] [Abstract][Full Text] [Related]
24. [Does addiction to antidepressants exist? About a case of one addiction to tianeptine].
Guillem E; Lépine JP
Encephale; 2003; 29(5):456-9. PubMed ID: 14615695
[TBL] [Abstract][Full Text] [Related]
25. Activation syndrome induced by the antidepressant tianeptine and suicidal ideation: Evidence from a large depressed outpatient sample.
Lopez-Castroman J; Jaussent I; Gorwood P; Courtet P
Prog Neuropsychopharmacol Biol Psychiatry; 2020 Mar; 97():109762. PubMed ID: 31526830
[TBL] [Abstract][Full Text] [Related]
26. Clinical safety and efficacy of tianeptine in 1,858 depressed patients treated in general practice.
Guelfi JD; Dulcire C; Le Moine P; Tafani A
Neuropsychobiology; 1992; 25(3):140-8. PubMed ID: 1407480
[TBL] [Abstract][Full Text] [Related]
27. Tianeptine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in depression and coexisting anxiety and depression.
Wilde MI; Benfield P
Drugs; 1995 Mar; 49(3):411-39. PubMed ID: 7774514
[TBL] [Abstract][Full Text] [Related]
28. Tianeptine abuse: yet again.
Prescrire Int; 2007 Oct; 16(91):201. PubMed ID: 17929386
[No Abstract] [Full Text] [Related]
29. [A case of tianeptine abuse].
Saatçioğlu O; Erim R; Cakmak D
Turk Psikiyatri Derg; 2006; 17(1):72-5. PubMed ID: 16528638
[TBL] [Abstract][Full Text] [Related]
30. Safety of tianeptine use in patients with epilepsy.
Moon J; Jung KH; Shin JW; Lim JA; Byun JI; Lee ST; Chu K; Lee SK
Epilepsy Behav; 2014 May; 34():116-9. PubMed ID: 24739449
[TBL] [Abstract][Full Text] [Related]
31. Neurobiological and clinical effects of the antidepressant tianeptine.
Kasper S; McEwen BS
CNS Drugs; 2008; 22(1):15-26. PubMed ID: 18072812
[TBL] [Abstract][Full Text] [Related]
32. Tianeptine: a review of its use in depressive disorders.
Wagstaff AJ; Ormrod D; Spencer CM
CNS Drugs; 2001; 15(3):231-59. PubMed ID: 11463130
[TBL] [Abstract][Full Text] [Related]
33. Acute and chronic tianeptine treatments attenuate ethanol withdrawal syndrome in rats.
Uzbay T; Kayir H; Celik T; Yüksel N
Prog Neuropsychopharmacol Biol Psychiatry; 2006 May; 30(3):478-85. PubMed ID: 16412550
[TBL] [Abstract][Full Text] [Related]
34. [Treatment with tianeptine for depressive disorders in the elderly].
Saiz Ruiz J; Montes JM; Alvarez E; Cervera S; Giner J; Guerrero J; Dourdil F; Seva A
Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1997; 25(2):79-83. PubMed ID: 9245193
[TBL] [Abstract][Full Text] [Related]
35. A Case of Opioid Overdose and Subsequent Death After Medically Supervised Withdrawal: The Problematic Role of Rapid Tapers for Opioid Use Disorder.
Chang DC; Klimas J; Wood E; Fairbairn N
J Addict Med; 2018; 12(1):80-83. PubMed ID: 28930773
[TBL] [Abstract][Full Text] [Related]
36. Case Report of Physiologic Phenibut Dependence Treated With a Phenobarbital Taper in a Patient Being Treated With Buprenorphine.
Brunner E; Levy R
J Addict Med; 2017; 11(3):239-240. PubMed ID: 28441273
[TBL] [Abstract][Full Text] [Related]
37. [Therapeutic effects of tianeptine in patients with depression and anxiety disorders with or without associated alcoholism].
Marey C; Ganry H; Delalleau B; Kamoun A
Presse Med; 1991 Nov; 20(37):1828-36. PubMed ID: 1836615
[TBL] [Abstract][Full Text] [Related]
38. Efficacy, tolerability and safety of tianeptine in special populations of depressive patients.
Vuković O; Marić NP; Britvić D; Cvetić T; Damjanović A; Prostran M; Jasović-Gasić M
Psychiatr Danub; 2009 Jun; 21(2):194-8. PubMed ID: 19556948
[TBL] [Abstract][Full Text] [Related]
39. Adjunctive tianeptine treatment for bipolar disorder: A 24-week randomized, placebo-controlled, maintenance trial.
Kauer-Sant'Anna M; Frey BN; Fijtman A; Loredo-Souza AC; Dargél AA; Pfaffenseller B; Wollenhaupt-Aguiar B; Gazalle FK; Colpo GD; Passos IC; Bücker J; Walz JC; Jansen K; Ceresér KM; Bürke Bridi KP; Dos Santos Sória L; Kunz M; Pinho M; Kapczinski NS; Goi PD; Magalhães PV; Reckziegel R; Burque RK; de Azevedo Cardoso T; Kapczinski F
J Psychopharmacol; 2019 Apr; 33(4):502-510. PubMed ID: 30835152
[TBL] [Abstract][Full Text] [Related]
40. Efficacy and safety of tianeptine in major depression: evidence from a 3-month controlled clinical trial versus paroxetine.
Waintraub L; Septien L; Azoulay P
CNS Drugs; 2002; 16(1):65-75. PubMed ID: 11772119
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
